-
July 18, 2013 MSD and Lupin announce Strategic Partnership to Co-market MSD’s 23-valent Pneumococcal polysaccharide vaccine (PPV) for Indian market
-
May 8, 2013 Lupin announces Executive Board Leadership Changes
-
May 8, 2013 Record Sales and Profits
-
April 26, 2013 Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets
-
April 17, 2013 Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets
-
April 12, 2013 Lupin launches its Oral Contraceptive DayseeTM Tablets in the US Market Generic of Seasonique® Tablets
-
March 22, 2013 Lupin Launches Generic Diovan HCT® Tablets
-
February 22, 2013 Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
-
January 31, 2013 Record Sales and Profits – Quarter III Results, FY 2012-13
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications